CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 

Frequency Therapeutics Inc 's Quick Ratio

FREQ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




FREQ Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 90.78 % 85.59 % -35.66 % -57.09 % -68.15 %
Y / Y Cash & cash equivalent Change -32.91 % -34.27 % -39.79 % -40.68 % -33.96 %
Quick Ratio MRQ 4.97 6.62 9.64 11.44 14.12
Overall Ranking # # # # #
Seq. Current Liabilities Change 19.34 % 37.7 % 6.5 % 9 % 16.1 %
Seq. Cash & cash equivalent Change -10.51 % -5.41 % -10.21 % -11.73 % -12.32 %



Quick Ratio third quarter 2022 Comment
Due to increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 4.97 above Frequency Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry Frequency Therapeutics Inc booked the highest Quick Ratio than Frequency Therapeutics Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are FREQ Segments?
See Quick Ratio FREQ on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Frequency Therapeutics Inc 's Current Liabilities $ 20 Millions Visit FREQ's Balance sheet
Frequency Therapeutics Inc 's Cash & cash equivalent $ 99 Millions Visit FREQ's Balance sheet
Source of FREQ's Sales Visit FREQ's Sales by Geography


Cumulative Frequency Therapeutics Inc 's Quick Ratio

FREQ's Quick Ratio for the trailling 12 Months

FREQ Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 90.78 % 85.59 % -35.66 % -57.09 % -68.15 %
Y / Y Cash & cash equivalent TTM Growth -32.91 % -34.27 % -39.79 % -40.68 % -33.96 %
Quick Ratio TTM 7.59 9.97 13.1 12.89 11.25
Total Ranking TTM # 198 # 424 # 59 # 219 # 321
Seq. Current Liabilities TTM Growth 19.34 % 37.7 % 6.5 % 9 % 16.1 %
Seq. Cash & cash equivalent TTM Growth -10.51 % -5.41 % -10.21 % -11.73 % -12.32 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $20.00 millions, average cumulative Quick Ratio decreased to 7.59 below the Frequency Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 86 other companies have achieved higher Quick Ratio than Frequency Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. 198.

Explain Quick Ratio?
What are FREQ Segments?
See Quick Ratio FREQ on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 87
Healthcare Sector # 136
Within the Market # 198


TTM Quick Ratio Statistics
High Average Low
13.1 8.11 3.64
(Mar 31 2022)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Lumos Pharma Inc   13.44 $ 73.666  Millions$ 5.483  Millions
Annexon Inc   13.33 $ 269.519  Millions$ 20.220  Millions
Larimar Therapeutics Inc   13.24 $ 124.699  Millions$ 9.420  Millions
Liquidia Corporation  13.18 $ 98.320  Millions$ 7.460  Millions
Xenetic Biosciences Inc   13.18 $ 13.848  Millions$ 1.051  Millions
Aclaris Therapeutics Inc   13.04 $ 248.062  Millions$ 19.023  Millions
Iveric Bio Inc   13.04 $ 320.535  Millions$ 24.588  Millions
Erasca Inc   12.86 $ 355.928  Millions$ 27.679  Millions
Arcutis Biotherapeutics Inc   12.86 $ 476.963  Millions$ 37.102  Millions
Kronos Bio Inc   12.85 $ 258.255  Millions$ 20.105  Millions
Verrica Pharmaceuticals Inc   12.82 $ 39.454  Millions$ 3.078  Millions
Lyell Immunopharma Inc   12.65 $ 648.132  Millions$ 51.217  Millions
Pepgen Inc   12.62 $ 195.783  Millions$ 15.519  Millions
Graybug Vision Inc   12.61 $ 43.627  Millions$ 3.460  Millions
Histogen Inc   12.41 $ 14.552  Millions$ 1.173  Millions
Reneo Pharmaceuticals Inc   12.28 $ 116.080  Millions$ 9.450  Millions
Cogent Biosciences Inc   12.28 $ 289.094  Millions$ 23.551  Millions
Cymabay Therapeutics Inc   12.07 $ 153.415  Millions$ 12.711  Millions
Rallybio Corporation  11.90 $ 132.420  Millions$ 11.130  Millions
Milestone Pharmaceuticals Inc   11.84 $ 77.233  Millions$ 6.522  Millions
Capricor Therapeutics inc   11.84 $ 46.614  Millions$ 3.937  Millions
Ideaya Biosciences Inc   11.80 $ 386.244  Millions$ 32.727  Millions
Allakos Inc   11.79 $ 325.320  Millions$ 27.588  Millions
Cormedix Inc   11.66 $ 59.000  Millions$ 5.062  Millions
Centessa Pharmaceuticals Plc  11.65 $ 444.843  Millions$ 38.191  Millions
Metacrine Inc   11.65 $ 52.752  Millions$ 4.529  Millions
Medicinova Inc   11.60 $ 52.507  Millions$ 4.528  Millions
Ventyx Biosciences Inc   11.57 $ 412.423  Millions$ 35.661  Millions
Hcw Biologics Inc   11.44 $ 26.224  Millions$ 2.293  Millions
Diffusion Pharmaceuticals Inc   11.39 $ 25.858  Millions$ 2.271  Millions

Date modified: 2022-11-10T15:28:51+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LOW's Profile

Stock Price

LOW's Financials

Business Description

Fundamentals

Charts & Quotes

LOW's News

Suppliers

LOW's Competitors

Customers & Markets

Economic Indicators

LOW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071